Goldman Sachs Group Inc. is lining up about €2.5 billion ($2.7 billion) of debt financing for the potential sale of French biometrics and identity verification firm
Advent International, the private equity firm that owns Idemia, has been working with bankers to prepare the sales process and the company could fetch at least €4 billion, according to people familiar with the matter.
Idemia is attracting initial interest from companies such as France’s Thales SA as well as investment firms including Brookfield Asset Management Ltd. and Apollo Global Management Inc., said the people, who asked not to be identified because ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
